Quarterly report pursuant to Section 13 or 15(d)

Loans Receivable - Components (Details)

v3.24.3
Loans Receivable - Components (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2024
Dec. 31, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total loans receivable   $ 5,501 $ 5,501 $ 8,968
Less allowance for expected credit losses   (4,556) (4,556) (7,902)
Loans receivable   945 945 1,066
Additional allowance for credit losses   0 0  
Teneo Fund SPVi LLC note        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total loans receivable   $ 5,501 $ 5,501 5,622
Pharma EU, LLC note        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total loans receivable       1,410
A&R note        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total loans receivable       710
SSZ and Elev8 note        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total loans receivable       1,002
Pure Hana Synergy note        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total loans receivable       $ 224
Little Beach Harvest Note        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total loans receivable $ 0      
Write off of loan receivable including both principal and accrued interest $ 5,135